MarketInOut Stock Screener Log In | Sign Up

Pharmesis International Ltd

SES • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026
Pharmesis International Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSES
Market Capitalization3.01 mln
Float6.77 mln
Earnings Date02/26/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

8.17
Highly suspicious

Relative Strength

0 / 100
Severely lagging

Debt / Equity

0.30
Low leverage

Pre-Tax Margin

-25%
Deeply loss-making

ROE

-13.37
Negative

Business Description

Pharmesis International Ltd. is a Singapore-based company founded in 1996 that develops, manufactures, and sells both Western pharmaceuticals and traditional Chinese medicine products to hospitals and medical institutions across China. Its product range includes treatments for liver and gallbladder conditions, respiratory ailments, skin disorders, arthritis, and digestive problems, sold under the Kinna and Longlife brand names. The company also distributes a broad range of chemical drugs, biological products, antibiotics, and herbal medicines throughout the region.

Key Fundamentals

EPS-0.04
ROE-13.37
ROIC-11.92
ROA-8.27
EBITDA, mln-0.65
EV / EBITDA-8.98
EV / EBIT-4.91
Revenue, mln5.29
EV / Revenue1.11

Quote Details

Last 0.100
Change 0.005 (5.26%)
Open 0.100
Volume 100
Turnover 10
Average Volume 3,633.33

Financial Ratios

Pre-Tax Profit Margin-25
Current Ratio0.86
Price / Book0.41
Price / Tangible Book0.42
Price / Free Cash Flow8.33
Debt / Equity0.30
Price / Sales0.75

Financial Strength

Altman Z-Score0.68
Piotroski F-Score 4 / 9
Beneish M-Score8.17
Price to Intrinsic Value0.74

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 29.87% 99 / 100   
1 Month -72.22% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog